View of Patient-Reported Quality of Life After Hypofractionated Versus Conventional Adjuvant Radiotherapy for Stage IIB–IIIC Breast Cancer: A Prospective 12-Month Cohort Study from Uzbekistan

Return to Article Details Patient-Reported Quality of Life After Hypofractionated Versus Conventional Adjuvant Radiotherapy for Stage IIB–IIIC Breast Cancer: A Prospective 12-Month Cohort Study from Uzbekistan Download Download PDF